Department of Paediatric Intensive Care, Queensland Children's Hospital, Brisbane, Qld, Australia.
School of Medicine, University of Queensland, Brisbane, Qld, Australia.
Crit Care Med. 2020 Nov;48(11):e1071-e1078. doi: 10.1097/CCM.0000000000004622.
Milrinone is an inodilator widely used in the postoperative management of children undergoing cardiac surgery. The literature supporting its inotropic effect is sparse. We sought to study the effect of milrinone on the vasculature and its effects on the ventricular function using wave intensity analysis. We also intended to evaluate the feasibility of using wave intensity analysis by the bedside.
prospective single-center observational study.
PICU of a tertiary children's hospital.
Children (< 18 yr) admitted to PICU following cardiac surgery who required to be commenced on a milrinone infusion.
Echocardiography and Doppler ultrasound assessments for wave intensity analysis were performed prior to commencing milrinone and 4-6 hours after milrinone infusion.
Wave intensity analysis was successfully performed and analyzed in 15 of 16 patients (94%). We identified three waves-a forward compression wave, backward compression wave, and forward decompression wave. The waves were described with their cumulative intensity and wave-related pressure change. There was a 26% reduction in backward compression wave cumulative intensity following the introduction of milrinone. Other variables (backward compression wave cumulative intensity/forward compression wave cumulative intensity ratio, backward compression wave wave-related pressure change, backward compression wave wave-related pressure change/forward compression wave wave-related pressure change ratio) consistent with vasodilation also decreased after milrinone. It also decreased the vascular wavespeed by 7.1% and increased the distensibility of the vessels by 14.6%. However, it did not increase forward compression wave cumulative intensity, a variable indicating the systolic force generated by the ventricle. Forward decompression wave cumulative intensity indicating ventricular early diastolic relaxation also did not change.
In a cohort of children recovering in PICU after having undergone cardiac surgery, we found that milrinone acted as a vasodilator but did not demonstrate an improvement in the contractility or an improved relaxation of the left ventricle as assessed by wave intensity analysis. We were able to demonstrate the feasibility and utility of wave intensity analysis to further understand ventriculo-vascular interactions in an intensive care setting.
米力农是一种在心脏手术后患儿术后管理中广泛使用的正性肌力药物和血管扩张剂。关于其正性肌力作用的文献很少。我们试图使用波动强度分析来研究米力农对血管的作用及其对心室功能的影响。我们还旨在评估床边使用波动强度分析的可行性。
前瞻性单中心观察性研究。
三级儿童医院的 PICU。
心脏手术后入住 PICU 并需要开始米力农输注的儿童(<18 岁)。
在开始米力农输注之前和米力农输注 4-6 小时后,进行超声心动图和多普勒超声评估以进行波动强度分析。
16 例患者中有 15 例(94%)成功进行了波动强度分析。我们识别出了三个波,一个前向压缩波、一个后向压缩波和一个前向减压波。描述了这些波的累积强度和与波相关的压力变化。在引入米力农后,后向压缩波累积强度降低了 26%。其他变量(后向压缩波累积强度/前向压缩波累积强度比值、后向压缩波与波相关的压力变化、后向压缩波与波相关的压力变化/前向压缩波与波相关的压力变化比值)也与血管扩张一致,在米力农后也降低了。它还使血管波速降低了 7.1%,使血管的顺应性增加了 14.6%。然而,它并没有增加前向压缩波累积强度,这是一个表示心室产生的收缩力的变量。表明心室早期舒张松弛的前向减压波累积强度也没有变化。
在心脏手术后在 PICU 中恢复的儿童队列中,我们发现米力农作为血管扩张剂,但波动强度分析并未显示其收缩力或左心室舒张功能改善。我们能够证明波动强度分析的可行性和实用性,以进一步了解重症监护环境中的心室-血管相互作用。